TLX Competitors & Alternatives
Compare Telix Pharmaceuticals Limited with similar stocks in the same industry
Biotechnology
TLX
Main Stock$9.56
Tradestie Score
56
Market Cap
$3.40B
Revenue Growth
0.5%
Analyst Upside
+117.9%
Top Competitors
220 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
QURE
uniQure N.V.
|
$27.68
|
$3.39B | - | 56 | Compare |
|
SRRK
Scholar Rock Holding Corporation Common Stock
|
$45.27
|
$3.33B | - | 51 | Compare |
|
NAMS
NewAmsterdam Pharma Company N.V. Ordinary Shares
|
$30.51
|
$3.31B | - | 51 | Compare |
|
SLNO
Soleno Therapeutics, Inc. Common Stock
|
$53.01
|
$3.20B | 27.5 | 49 | Compare |
|
MLYS
Mineralys Therapeutics, Inc. Common Stock
|
$23.84
|
$3.09B | - | 53 | Compare |
|
VKTX
Viking Therapeutics, Inc
|
$29.39
|
$3.08B | - | 53 | Compare |
|
CNTA
Centessa Pharmaceuticals plc American Depositary Shares
|
$39.79
|
$3.03B | - | 59 | Compare |
|
XENE
Xenon Pharmaceuticals Inc
|
$52.03
|
$3.02B | - | 58 | Compare |
|
CGON
CG Oncology, Inc. Common stock
|
$59.65
|
$3.01B | - | 60 | Compare |
|
APLS
Apellis Pharmaceuticals, Inc. Common Stock
|
$41.03
|
$2.92B | 38.3 | 59 | Compare |
More TLX Analysis
Data updated: Jun 15, 2026 | Industry: Biotechnology (SIC 2834)
220 stocks in this industry